Advertisement

Loading...

Antengene Corporation Limited

6996.HKHKSE
Healthcare
Biotechnology
HK$5.33
HK$0.63(13.40%)
Hong Kong Market is Open • 10:08

Antengene Corporation Limited (6996.HK) Stock Competitors & Peer Comparison

See (6996.HK) competitors and their performances in Stock Market.

Peer Comparison Table: Biotechnology Industry

Detailed financial metrics including price, market cap, P/E ratio, and more.

SymbolPriceChange %Market CapP/E RatioEPSDividend Yield
6996.HKHK$5.36+14.04%3.3B-12.47-HK$0.43N/A
6160.HKHK$185.00+7.81%277.9B124.16HK$1.49N/A
1801.HKHK$90.90+7.07%156.4B171.51HK$0.53N/A
2269.HKHK$34.86+5.57%144.1B26.61HK$1.31N/A
9926.HKHK$139.20+6.91%128.1B-127.71-HK$1.09N/A
1177.HKHK$6.36+7.98%113.8B42.40HK$0.15+1.42%
9995.HKHK$110.40+15.24%60.7B75.10HK$1.47N/A
1530.HKHK$25.32+11.84%59.7B23.23HK$1.09+0.99%
3759.HKHK$20.88+10.95%57B21.53HK$0.97+1.05%
2696.HKHK$75.90+8.82%41.3B44.39HK$1.71N/A
1

Stock Comparison

Select a stock to compare (requires JavaScript). Showing default comparison.

6996.HK vs 6160.HK Comparison April 2026

6996.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, 6996.HK stands at 3.3B. In comparison, 6160.HK has a market cap of 277.9B. Regarding current trading prices, 6996.HK is priced at HK$5.36, while 6160.HK trades at HK$185.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

6996.HK currently has a P/E ratio of -12.47, whereas 6160.HK's P/E ratio is 124.16. In terms of profitability, 6996.HK's ROE is -0.34%, compared to 6160.HK's ROE of +0.07%. Regarding short-term risk, 6996.HK is more volatile compared to 6160.HK. This indicates potentially higher risk in terms of short-term price fluctuations for 6996.HK.Check 6160.HK's competition here

Stock price comparison of stocks in the Healthcare Sector

Loading...

Frequently Asked Questions